Despite US FDA Alert, Abbott-Muddy Waters Lawsuit Continues
Executive Summary
St. Jude appears to still be pursuing legal action against Muddy Waters, despite an FDA alert that seems to vindicate the short-seller's discovery of cybersecurity vulnerabilities with the device-maker's wireless implantable cardiac products.
You may also be interested in...
Abbott Issues New Cybersecurity Patch For Cardiac Devices
After Abbott recently settled a case against short-seller Muddy Waters, the company has put out a second cybersecurity patch for certain St. Jude radio-frequency enabled cardiac devices to stop potential hackers from harming patients.
Multiple Hacking Risks Found In Another Infusion Pump
After a hacker brought the issue to the attention of Smiths Medical, the company engaged US FDA and the Department of Homeland Security, which alerted users that Smith's Medfusion 4000 wireless syringe infusion pumps are at risk from multiple cybersecurity vulnerabilities.
US FDA Warning Letter Scrutinizes Abbott Over Cybersecurity, Battery Lapses
FDA investigators are concerned Abbott's St. Jude Medical subsidiary failed to adequately address concerns over cybersecurity vulnerabilities and premature battery drain on their cardiac devices manufactured at its Sylmar, Calif., facility.